• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virus Evol . The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia

tetano

Editor, Senior Moderator
Virus Evol


. 2022 Mar 5;8(1):veac017.
doi: 10.1093/ve/veac017. eCollection 2022.
The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia


Galya V Klink[SUP] 1 [/SUP], Ksenia R Safina[SUP] 1 [/SUP], Elena Nabieva[SUP] 2 [/SUP], Nikita Shvyrev[SUP] 3 [/SUP], Sofya Garushyants[SUP] 1 [/SUP], Evgeniia Alekseeva[SUP] 2 [/SUP], Andrey B Komissarov[SUP] 4 [/SUP], Daria M Danilenko[SUP] 4 [/SUP], Andrei A Pochtovyi[SUP] 5 [/SUP], Elizaveta V Divisenko[SUP] 5 [/SUP], Lyudmila A Vasilchenko[SUP] 5 [/SUP], Elena V Shidlovskaya[SUP] 5 [/SUP], Nadezhda A Kuznetsova[SUP] 5 [/SUP], Coronavirus Russian Genetics Initiative (CoRGI) Consortium; Anna S Speranskaya[SUP] 6 [/SUP], Andrei E Samoilov[SUP] 6 [/SUP], Alexey D Neverov[SUP] 6 [/SUP], Anfisa V Popova[SUP] 6 [/SUP], Gennady G Fedonin[SUP] 6 [/SUP], CRIE Consortium; Vasiliy G Akimkin[SUP] 6 [/SUP], Dmitry Lioznov[SUP] 4 [/SUP], Vladimir A Gushchin[SUP] 5 [/SUP], Vladimir Shchur[SUP] 3 [/SUP], Georgii A Bazykin[SUP] 2 [/SUP]



Affiliations

Abstract

Delta has outcompeted most preexisting variants of SARS-CoV-2, becoming the globally predominant lineage by mid-2021. Its subsequent evolution has led to the emergence of multiple sublineages, most of which are well-mixed between countries. By contrast, here we show that nearly the entire Delta epidemic in Russia has probably descended from a single import event, or from multiple closely timed imports from a single poorly sampled geographic location. Indeed, over 90 per cent of Delta samples in Russia are characterized by the nsp2:K81N + ORF7a:P45L pair of mutations which is rare outside Russia, putting them in the AY.122 sublineage. The AY.122 lineage was frequent in Russia among Delta samples from the start, and has not increased in frequency in other countries where it has been observed, suggesting that its high prevalence in Russia has probably resulted from a random founder effect rather than a transmission advantage. The apartness of the genetic composition of the Delta epidemic in Russia makes Russia somewhat unusual, although not exceptional, among other countries.

Keywords: AY.122; Delta lineage; ORF7a:P45L; SARS-CoV2 in Russia; cross-border transmission of SARS-CoV2; genomic epidemiology of SARS-CoV2.
 
Back
Top Bottom